VOR
Vor Biopharma Inc.
Key Financials
Net Income
$-695981000
↓ 495.3%
Operating Income
$-371642000
↓ 206.7%
EPS (Diluted)
$-70.50
↓ 4047.1%
Total Assets
$464.1M
↑ 224.8%
Total Liabilities
$628.4M
↑ 1259.5%
Cash & Equivalents
$396.5M
↑ 383.8%
Shareholders' Equity
$-164312000.00
↓ 270.0%
Operating Cash Flow
$-142713000.00
↓ 43.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 10-Q | 8/11/2026 | View on SEC |
| SCHEDULE 13G/A | 8/7/2026 | View on SEC |
| SCHEDULE 13G | 8/6/2026 | View on SEC |
| SCHEDULE 13G | 7/30/2026 | View on SEC |
| SCHEDULE 13D/A | 7/21/2026 | View on SEC |
| 4 | 7/21/2026 | View on SEC |
| 3 | 7/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VOR |
| Company Name | Vor Biopharma Inc. |
| CIK | 1817229 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 617-655-6580 |